Skip to main content

Advertisement

Table 2 Microbiological findings

From: Prevalence, risk factors and outcomes of patients coming from the community with sepsis due to multidrug resistant bacteria

Microbiological, n (%)
Patients with isolated microorganism 305 (58.9)
Patients with at least one MDR organism 88 (17.0)
Patients with at least one ESBL organism 50 (9.7)
E. coli ESBL + 43 (8.3)
Methicillin-resistant S. aureus 20 (3.9)
Proteus spp MDR + 5 (1)
K. pneumoniae ESBL + 7 (1.4)
K. pneumomiae carbapenemase producer 6 (1.2)
P. aeruginosa MDR+ 4 (0.8)
Enterococcus spp MDR+ 2 (0.4)
Enterobacter spp MDR + 2 (0.4)
Stenotrophomonas maltophilia MDR+ 1 (0.2)
E. coli ESBL - 77 (14.9)
Methicillin-sensible S. aureus 24 (4.6)
S. pneumoniae 24 (4.6)
K. pneumoniae ESBL- 17 (3.3)
P. aeruginosa MDR- 25 (4.8)
Candida spp 12 (2.3)
Enterococcus spp MDR- 10 (1.9)
Proteus spp MDR-) 9 (1.7)
Enterobacter spp MDR- 5 (1)
N. meningitides 3 (0.6)
Bacteroides spp 1 (0.2)
Providencia spp 2 (0.4)
Stenotrophomonas maltophilia MDR- 3 (0.6)
C. difficile 4 (0.8)
Aspergillus spp 2 (0.4)
Acinetobacter baumanii 1 (0.2)
Salmonella group B 2 (0.4)
H. influenzae 1 (0.2)
Acinetobacter iwoffii 1 (0.2)
Propiniobacterium 1 (0.2)
Serratia spp 2 (0.4)
Polymicrobial infection 29 (5.6)
  1. n number, ESBL extended spectrum beta lactamase, MDR multi-drug resistant, spp species